Navigation Links
Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
Date:6/25/2008

- Once-daily dosing with enteric-coated tablet produced robust antiviral

activity - - RDEA806 was well tolerated during one week of dosing in HIV patients -

SAN DIEGO, June 25 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced additional positive results from its completed Phase 2a proof-of-concept monotherapy study of RDEA806, its novel investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), in patients with human immunodeficiency virus (HIV).

These additional results demonstrated that once-daily dosing with the enteric-coated tablet formulation of RDEA806 resulted in significant reductions in plasma viral load that were consistent with results previously presented with twice-daily dosing of the capsule formulation in the same study. All dosing regimens tested in the study were well tolerated. Ardea's lead investigator plans to present the full data from this study at a medical conference later this year.

"RDEA806's robust antiviral potency, combined with its excellent tolerability profile in over 130 healthy volunteers and HIV-infected patients treated in clinical studies to-date, make RDEA806 a promising candidate for further investigation as a first-line agent for the treatment of HIV," said Dr. Graeme Moyle, Director of HIV Research, Chelsea and Westminster Hospital, and a lead investigator in the completed Phase 2a trial and planned Phase 2b study.

Phase 2a Clinical Trial Design & Top-line Results

The Phase 2a randomized, double-blind, placebo-controlled trial evaluated the antiviral activity, pharmacokinetics, safety and tolerability of once- and twice-daily oral dosing regimens of RDEA806 versus placebo in 48 HIV-pos
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
2. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
3. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
4. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
5. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
6. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
7. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
10. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
11. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... May 27, 2015  With all the daily obstacles ... they provide to keep patients healthy should be easy. ... of the Affordable Care Act continues to affect the ... partners, making it more important than ever that medical ... those they contract with for patient care. ...
(Date:5/27/2015)... May 26, 2015 Research and Markets( http://www.researchandmarkets.com/research/nt9zlx/asia_pacific ... Pacific Mammography Market - Growth, Trends And Forecasts (2014 ... Mammography is a detailed type of imaging that ... mammography exam, called a mammogram, is used to support ... in women. An x-ray (radiograph) is a noninvasive medical ...
(Date:5/27/2015)... May 27, 2015 Water Street ... on the health care industry, announced today that ... one of the world,s leading global health care ... which the firm established in 2013 as a ... investment in developing pharmaceutical products and medical devices. ...
Breaking Medicine Technology:Physicians Seek Payer Inclusion, Not Impediment 2Physicians Seek Payer Inclusion, Not Impediment 3Asia Pacific Mammography Market Trends and Forecasts 2015-2019 2Water Street Announces Pharmaceutical Development Partnership with Global Health Care Company 2
... 65-69 who break a hip are five times more likely to ... don,t break a hip, according to a Kaiser Permanente Center for ... published online today in the Archives of Internal Medicine. ... group. In addition to the finding for women ages 65-69, it ...
... LINCOLN, Calif., Sept. 26, 2011 Safely storing ... parents and other prescription holders. Now, an innovative ... and store dangerous medications—in a small, convenient and ... http://photos.prnewswire.com/prnh/20110926/SF75139 ) Developed by CAP-N-LOCK, ...
Cached Medicine Technology:Elderly Women Who Break a Hip at Increased Risk of Dying Within a Year 2Elderly Women Who Break a Hip at Increased Risk of Dying Within a Year 3Elderly Women Who Break a Hip at Increased Risk of Dying Within a Year 4New Combination Locking Cap Designed to Protect Children and Teens From Prescription Medications 2
(Date:5/27/2015)... Milwaukee, Wis. (PRWEB) May 27, 2015 ... said Julie Schuller, MD, executive vice president and vice ... capacity this grant makes possible allows us to provide ... health of our community.” , SSCHC provides clinical care ... served over 35,000 people in 2014, many of whom ...
(Date:5/27/2015)... With the launch of the Centers ... Management Module (NMM) tool, monitoring provider-network adequacy will take ... Atlantic Information Services, Inc.’s (AIS) Medicare Advantage News (MAN) ... well as analysis from industry experts on why CMS ... to the NMM were announced at CMS’s recently held ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Dr. Omar ... based in Stamford, CT has been selected as part ... first physicians nationwide (and the only physician in Connecticut) ... which allows for the removal of submental fat (double ... no recovery time, no surgery and minimal risks. Dr. ...
(Date:5/27/2015)... New Hampshire (PRWEB) May 27, 2015 ... in the April 2015 issue of the Journal of ... diet sodas and abdominal obesity, Bedford Commons OB-GYN ... water instead of non-nutritive sweetener-flavored beverages. , To ... waist circumference, a comprehensive San Antonio Longitudinal Study of ...
(Date:5/27/2015)... SAN DIEGO, May 27, 2015 – ... first healthcare provider along the Gulf Coast to ... (CCM). In partnership with MD Revolution, a digital ... new program that enables healthcare providers to easily ... This new, user-friendly program is designed to improve ...
Breaking Medicine News(10 mins):Health News:Sixteenth Street Community Health Centers To Expand Primary Care and Behavioral Health Services Through $1 Million Grant From Aurora's Better Together Fund 2Health News:AIS Newsletter Offers Coverage, Analysis of New CMS Strategy on Monitoring MA Provider Access 2Health News:AIS Newsletter Offers Coverage, Analysis of New CMS Strategy on Monitoring MA Provider Access 3Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 3Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 3
... Failing Marks for its Lack of Overall Plan and,Sense ... Cancer,Alliance-CA (LCA-CA) issued its 1st annual Report Card on ... grades to the state for its lack,of progress in ... each year than all other major cancer combined., ...
... The fourth annual EagleBank,Foundation Fight Breast Cancer Golf ... the primary beneficiaries: Shady Grove,Adventist Hospital and Suburban ... University Hospital, Providence Hospital and Washington,Hospital Center in ... of Montgomery County. The tournament was held on ...
... Nov. 13 /PRNewswire-FirstCall/ - Predictive medicine company,PreMD Inc. (TSX: PMD; ... the third quarter of fiscal 2008 ended,September 30, 2008 ("Q3 ... - the PREVU* appeal is being reviewed ... - the agreement with AstraZeneca has been ...
... Barbara, Calif.) A $3.8 million Innovator Award, from ... years to an internationally renowned cancer researcher at the ... recipient of the award, is known for his innovative, ... are only four of them," said Ruoslahti. "I am ...
... Corp (Amex: CHM , CHMU, CHMW) ("CHM") ... Teambest International, Ltd. and,Madame Wang Lahua (collectively, "Seller") ... to terminate the stock purchase agreement among,them pursuant ... of the outstanding,equity of Europe Asia Huadu Environment ...
... OLATHE, Kan., Nov. 13 In yet another sign ... and human,health sectors, an estimated 150 scientists from around ... University for an international,symposium on zoonotic diseases, which are ... On Nov. 13-14, researchers and clinicians from as far ...
Cached Medicine News:Health News:Lung Cancer Alliance-California Issues Inaugural State-Specific Report Card on Lung Cancer 2Health News:Fourth Annual EagleBank Foundation Fight Breast Cancer Golf Classic Raises Over $100,000 2Health News:PreMD Inc. Reports Third Quarter Results and Appoints New Chief Financial Officer 2Health News:PreMD Inc. Reports Third Quarter Results and Appoints New Chief Financial Officer 3Health News:PreMD Inc. Reports Third Quarter Results and Appoints New Chief Financial Officer 4Health News:PreMD Inc. Reports Third Quarter Results and Appoints New Chief Financial Officer 5Health News:PreMD Inc. Reports Third Quarter Results and Appoints New Chief Financial Officer 6Health News:PreMD Inc. Reports Third Quarter Results and Appoints New Chief Financial Officer 7Health News:PreMD Inc. Reports Third Quarter Results and Appoints New Chief Financial Officer 8Health News:PreMD Inc. Reports Third Quarter Results and Appoints New Chief Financial Officer 9Health News:PreMD Inc. Reports Third Quarter Results and Appoints New Chief Financial Officer 10Health News:PreMD Inc. Reports Third Quarter Results and Appoints New Chief Financial Officer 11Health News:PreMD Inc. Reports Third Quarter Results and Appoints New Chief Financial Officer 12Health News:PreMD Inc. Reports Third Quarter Results and Appoints New Chief Financial Officer 13Health News:Cancer researcher receives $3.8 million award from US Department of Defense 2Health News:China Healthcare Acquisition Corp Agrees to Terminate Agreement to Acquire Europe Asia Huadu Environment Holding Pte, Ltd. 2Health News:Leading Scientists From Around the World Headed to Kansas for Symposium on Combating Deadly Infectious Diseases 2
... USA Elite System™ and ... are utilized for incision ... bladder neck contractures under ... obturator converts the visual ...
... tube, the FCY-15P2 allows for easy ... strictured areas. It features a ... in air and 83 in water, ... simplifying orientation. A great scope ...
... The new EndoEYE Flexible Video Cystoscope ... in surgical technology. By marrying proprietary video ... design, Olympus is now providing a flexible ... to that of a rigid rod lens ...
... is the next generation in ... symptoms of BPH. This dual-action ... prostate while dilating the prostatic ... tolerated by patients and most ...
Medicine Products: